United Therapeutics is throwing its pulmonary arterial hypertension drug esuberaprost on the scrap heap after failing in a phase 3 test.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,